We've raised a $700M Series C, led by @lightspeedvp and co-led by O.G. Venture Partners. Since 2023, more than 350,000 people have signed up for a Neko Health Scan, and 100,000 people have experienced one. Today, our approach to redefining how people understand and act on their health is already working: for returning members, our data shows that 5 out of 7 of their key health markers showed statistically significant improvement between scans. This funding will scale our research into the hidden causes of disease and the development of proprietary technology to detect it before it has time to develop. It will also fund our continued expansion, including to the US, where our first clinic is set to open in New York this year. This round comes weeks after our biggest update yet to the Neko Health Scan, with body composition measures and clinician review of wearable data now included in all scans across our clinics in the UK and Sweden. We're grateful for the continued support of @atomico, @generalcatalyst, and Lakestar, and welcome new investors including Liberty City Ventures, Positive Sum, and BDT & MSD Partners.